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ABSTRACT

Retinal axons of the right and left eyes were labeled
at postnatal day (P) 9 by injection of cholera toxin B
(CTB)-Alexa Fluor 488 (green) and CTB-Alexa Fluor
594 (magenta), respectively. The left dorsal lateral
geniculate nucleus (dLGN) in coronal sections
prepared at P12 are shown. In wild type, ipsilateral
axons are conﬁned to a single patch in the inner
region of the dLGN, and contralateral axons
terminate in the surrounding areas. In contrast, in
Nell2 null (Nell2-/-) mice contralateral axons invade
the ipsilateral area (asterisks), forming a mosaic
pattern of contralateral and ipsilateral axons. Dorsal
is at the top and lateral is on the left.

Correct functioning of the nervous system critically depends on the
formation of the precise neuronal network. Axons of retinal ganglion
cells from the right and left eyes project to diﬀerent domains in the
lateral geniculate nucleus of the thalamus. This eye-speciﬁc
retinogeniculate projection provides the anatomical basis for
binocular vision. Nell2 (neural epidermal growth factor (EGF)-like-like
2) is an extracellular glycoprotein that is predominantly expressed in
the nervous system. Our lab has previously shown that Nell2 acts as
an inhibitory axon guidance molecule in the establishment of the
eye-speciﬁc retinogeniculate projection. The current work aims to
identify the Nell2 receptor in retinal axon guidance. By using
immunohistochemistry, we found that the receptor tyrosine kinase
Ros1, which binds to Nell2, is expressed in the developing chick
retinal ganglion cells. Our results suggest that Ros1 may act as a
receptor for Nell2 in retinal ganglion cells and play a signiﬁcant role
in the establishment of the eye-speciﬁc retinogeniculate projection.

Explants of the ventrotemporal
(containing ipsilaterally projecting retinal
ganglion cells (RGCs)) (A,C) and
ventronasal (containing contralaterally
projecting RGCs) (B,D) retinae were
prepared from day 15.5 mouse embryos
and cultured for 72 h on a substratum
coated with Nell2-AP (Fusion protein of
N ell2 with an alkaline phosphatase tag)
(A,B) or control AP (unconjugated
alkaline phosphatase) (C,D), and axon
outgrowth was quantiﬁed (E) (n=4 for
each condition). Nell2-AP signiﬁcantly
inhibited outgrowth of ventronasal
retinal axons.

BACKGROUND

METHODS
● Cryosectioning

In vertebrates that have binocular vision, retinal axons project to the both
side of the brain. Retinal axons from the ipsilateral (same side) and the
contralateral (opposite side) eyes project to diﬀerent layers/domains of the
brain target, the dorsal lateral geniculate nucleus (dLGN) in the thalamus.

○ Fix the dissected eyes with 4% paraformaldehyde at 4°C overnight
○ Cryoprotect with 30% sucrose at 4°C overnight
○ Embed the tissues in OCT compound and freeze
○ Cryosectioning at 10 µm
● Immunohistochemistry
○ Rinse the slides with PBS for 5 min x3
○ Antigen retrieval with 10 mM citrate (pH 6.0), 0.05% Tween-20
○ Treat with 3%H2O2 for 10 min, Rinse with PBS for 5 min x3
○ Blocking with 10% goat serum
○ Incubate with primary antibody for 1 hr. Rinse with PBS for 5 min x3
○ Incubate with secondary antibody for 1 hr. Rinse with PBS for 5 min x3.
○ Incubate with Elite ABC reagents for 30 min
○ Rinse with PBS for 5 min x3 and then with TBS for 5 min
○ Incubate with DAB for 30 min

RESULTS

(A-C) Nell2 expression in the developing dorsal lateral geniculate
nucleus (dLGN) was detected by RNA in situ hybridization in postnatal
day (P) 4-12 mice (purple). (D) Retinal axons from the ipsilateral retina
were labeled with an axon tracer dye (white). Nell2 is expressed in the
domain of the dorsomedial dLGN where ipsilateral axons terminate.

Retinal sections were prepared
from chick embryos at embryonic
day (E) 9 and E14 and subjected to
immunohistochemistry using
anti-Ros1 and anti-Brn3a
antibodies. Ros1 expression was
detected in retinal ganglion cells
(RGCs) (at E9 and E14) and in optic
nerve ﬁbers (ONFs) (at E14). Brn-3a
is a marker of RGCs. The sections
were counterstained with
hematoxylin. Scale bars, 50 μm.

CONCLUSIONS

A model of the function of Nell2-Ros1 interaction in the
eye-speciﬁc visual projection. Nell2 is expressed in the
dorsomedial domain of the dorsal lateral geniculate nucleus
(dLGN), where ipsilateral axons terminate (Ipsilateral domain).
Ros1 is expressed in contralaterally projecting retinal ganglion
cells. The Nell2-Ros1 interaction mediates a contralateral retinal
axon-speciﬁc repulsion in the dLGN. Contralateral RGC axons are
repelled by Nell2, and thus they avoid the ipsilateral domain and
project to the surrounding contralateral domain. In contrast,
ipsilateral axons can project to the ipsilateral domain. Ipsilateral
axons do not terminate in the contralateral domain because
there is greater axon-axon competition, thus they prefer to avoid
this competition and arborize only in the ipsilateral domain. In
Nell2−/− mice, the Nell2-mediated repulsion is removed, and
contralateral axons can now invade the ipsilateral domain and
compete more eﬀectively with ipsilateral axons there. Subsets of
the ipsilateral axons lose competition and spread out into
surrounding areas in the contralateral domain.

FUTURE DIRECTIONS
In future studies, we will investigate the function of Ros1 in the
eye-speciﬁc visual projection by using genetically modiﬁed mice
in which the Ros1 gene is deleted (Ros1 knockout mice) and in
vitro axon behavior assays. We will also study Ros1 functions in
chick, where the Nell2-Ros1 may be involved in the layer-speciﬁc
visual projection. We expect that our research will provide novel
insights into the molecular mechanisms for development of
binocular vision and neuronal network formation.
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